| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 09 Mar 2026 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | +9,500 | +7308% | $146.03* | 9,630 | 05 Mar 2026 | Direct | F1 | |
| transaction | UTHR | Common Stock | Sale | $133,889 | -279 | -2.9% | $479.89 | 9,351 | 05 Mar 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $231,148 | -481 | -5.1% | $480.56 | 8,870 | 05 Mar 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $245,844 | -510 | -5.7% | $482.05 | 8,360 | 05 Mar 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $624,422 | -1,293 | -15% | $482.92 | 7,067 | 05 Mar 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $836,435 | -1,728 | -24% | $484.05 | 5,339 | 05 Mar 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $1,273,121 | -2,625 | -49% | $485.00 | 2,714 | 05 Mar 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $387,990 | -798 | -29% | $486.20 | 1,916 | 05 Mar 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $583,938 | -1,199 | -63% | $487.02 | 717 | 05 Mar 2026 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $286,445 | -587 | -82% | $487.98 | 130 | 05 Mar 2026 | Direct | F1, F10 |
| holding | UTHR | Common Stock | 166 | 05 Mar 2026 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 05 Mar 2026 | by Trust | F11 | |||||
| holding | UTHR | Common Stock | 258,117 | 05 Mar 2026 | by Trust | F12 | |||||
| holding | UTHR | Common Stock | 45,596 | 05 Mar 2026 | by Trust | F13 | |||||
| holding | UTHR | Common Stock | 10,962 | 05 Mar 2026 | by Trust | F14 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Options | Options Exercise | -9,500 | -4.5% | $0.000000* | 202,000 | 05 Mar 2026 | Common Stock | 9,500 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. |
| F2 | This transaction was executed in multiple trades at prices ranging from $479.14 to $480.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $480.28 to $481.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $481.52 to $482.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $482.52 to $483.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $483.53 to $484.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $484.61 to $485.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $485.61 to $486.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $486.62 to $487.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $487.67 to $488.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F11 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F12 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F13 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F14 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |